Angioedema due to ACE inhibitors: common and inadequately diagnosed.
The estimated incidence of angioedema during angiotensin-converting enzyme (ACE) inhibitor treatment is between 1 and 7 per thousand patients.
This potentially serious adverse effect is often preceded by minor manifestations that may serve as a warning.